Product Reports Resources Pricing Login Book a demo

Huamei Haolian Medical Technology

Health Tech & Medtech · China

AI-powered digital health management solutions for insurers. MoreLess

Huamei Haolian Medical Technology (also known as E-Health Now) is a one-stop artificial intelligence digital health service technology group founded in 2017 by CEO Xu Bingyu. The company, with headquarters in Suzhou and an operations center in Beijing, has established a presence in major Chinese cities and the United States. Through a B2B2C business model, it provides health management service solutions and digital empowerment for clients in the insurance, banking, and corporate sectors.

The company's core services leverage AI technology and integrated medical resources to offer full-cycle health management, spanning pre-diagnosis, in-diagnosis, and post-diagnosis phases. Huamei Haolian has developed proprietary AI products such as "AI General Practitioner" and "AI Precise Medical Treatment," launched in 2022. Its core algorithms for "precise medical treatment" and "TCM inquiries" have received official备案 (bèi àn, record-filing) in the precision medicine field, and its health management large model has completed national-level generative AI service备案, positioning it as a compliant provider of large-scale AI applications.

Huamei Haolian provides a range of services including online consultations, video doctor appointments, green channel access for medical treatment, international multi-disciplinary consultations, and access to specialty drugs. As of early 2026, the company's network includes over 1,650 Grade-A tertiary hospitals in China and partnerships with more than 300 domestic medical institutions. It also has links to 8 international medical systems and nearly 3,000 international experts. The firm has served nearly 300 B2B clients and over 56 million end-users.

The company has secured significant funding through multiple rounds. A Series C round in July 2024 raised nearly 100 million yuan from investors including Amiba Capital, Ventech China, and Fengqiao Capital. This was followed by a Series D round of several hundred million yuan in March 2026, co-led by Yifeng Capital, YHLO, Ventech China, and Fengqiao Capital, with participation from Oriental Fortune Capital, GSR Ventures, and a Tongji University alumni fund.

Keywords: E-Health Now, digital health, AI medical, health management, B2B2C, insurtech, online consultation, video doctor, precision medicine, health data, AI algorithms, healthcare platform, corporate wellness, insurance services, medical network, healthcare technology, telemedicine, digital therapeutics, AI diagnostics

Company overview

Huamei Haolian Medical Technology company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
Headquarters
China
Employees
Open positions
None listed
Dealroom signal
13.6
client focusb2btechnologyArtificial Intelligencesub industryHealth Platformsub industryInsurancebusiness modelSaaSindustryHealthindustryFintechsectorCore AIsectorHealth InsurancesectorTech for Hospitals and ClinicssectorLandH InsurancesectorInsurtech Admin TechsectorHard Tech

Valuation & funding

Huamei Haolian Medical Technology funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES DEquity / VC Mar 2026 $28M $110M Ventech China · Shenzhen Yahuilong Biotechnology · Tongji Alumni Fund · GSR Ventures China
SERIES CEquity / VC Sep 2025 $0 Yuanyi Capital · CDH Investments
SERIES CEquity / VC Jul 2024 $14M $55M Ameba Capital · Borchid Capital · Ventech China
SERIES BEquity / VC May 2023 $2.8M $11M GSR Ventures · Tongji Alumni Fund · Ventech China · Langrun Investment
SERIES AEquity / VC Aug 2022 $2.8M $11M Borchid Capital · Tongji Alumni Fund
SERIES AEquity / VC Jun 2022 GSR Ventures · Ventech China
Showing 6 recorded eventsUnlock the complete deal history →

Growth signals

Huamei Haolian Medical Technology website traffic

Latest recorded traffic for Huamei Haolian Medical Technology is 1.7K monthly website visits, up 1316.7% over the last three months.

Latest monthly visits1.7K 3-month web change+1316.7%
Monthly website visits22 observations · Nov 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Huamei Haolian Medical Technology compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Huamei Haolian Medical Technology's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

12 investors on Huamei Haolian Medical Technology's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 5 investors entered at this stage
GSR Ventures
Ventech China
Borchid Capital
Tongji Alumni Fund
Langrun Investment
Series B+ 7 investors entered at this stage
Ameba Capital
Yuanyi Capital
CDH Investments
Shenzhen Yahuilong Biotechnology
Feng Qiao Capital
Yifeng Capital
GSR Ventures China

Global footprint

Where Huamei Haolian Medical Technology has talent and traffic

Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

In the news

Latest news about Huamei Haolian Medical Technology

Recent press, funding announcements, and product moves mentioning Huamei Haolian Medical Technology — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Huamei Haolian Medical Technology

An AI-synthesized read of the highest-engagement posts about Huamei Haolian Medical Technology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Huamei Haolian Medical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.